HLD Europe société en commandite par actions Luxembourgeoise

About HLD Europe société en commandite par actions Luxembourgeoise

HLD Europe, a Luxembourg-based partnership limited by shares, has established itself as a reference shareholder and long-term strategic investor in several European listed companies, including Clariane SE and Exosens. In listed-company governance, its role is defined by support for development, balance-sheet strengthening and industrial transformation. At Clariane, HLD Europe is represented by Julie Le Goff on the board of directors, where she sits on the Audit Committee and the Ethics, Quality and CSR Committee. This illustrates HLD Europe’s active involvement in governance oversight, financial discipline and non-financial responsibilities. One of HLD Europe’s most notable actions at Clariane was its participation in the capital-strengthening transaction announced in May 2024 and approved by the general meeting on 10 June 2024. HLD Europe joined Crédit Agricole Assurances as a reference shareholder in a broader plan designed to reinforce the group’s financial structure and support its corporate project, “At your side.” The transaction was a clear vote of confidence in Clariane’s restructuring and growth strategy. At Exosens, HLD Europe also plays a leading shareholder role. The group has supported the company since 2021 and backed its growth path, technology positioning and stock market listing. Exosens disclosures indicate that, following a partial share sale announced in October 2025, HLD Europe remains the company’s largest shareholder with 22.42% of share capital. Exosens also highlights HLD’s contribution to the company’s international expansion in detection and imaging technologies, an area that requires sustained investment, long-term vision and demanding governance. More broadly, HLD Europe is known for its expertise in growth capital, financial restructuring, support for sector leaders and sustainable value creation. Its presence in companies such as Clariane and Exosens reflects a conviction-led investment approach, a strong European footprint and an active governance philosophy. This combination of long-term capital, board-level engagement and strategic discipline is one of its key strengths.